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Background: As an alternative to chemical pesticides, paratransgenesis relies on transformation of symbiotic
bacteria of an arthropod vector to deliver molecules that disrupt pathogen transmission. For over a decade
paratransgenesis has remained a laboratory-based endeavor owing to regulatory concerns regarding introduction
of transformed microorganisms into the environment. To facilitate field application of paratransgenic strategies, risk
mitigation approaches that address environmental contamination and gene spread must be developed.
Results: Using biopolymer manipulation, we introduce a novel microencapsulation platform for containment and
targeted delivery of engineered bacteria to the gut of a disease-transmitting arthropod. We demonstrate the first
proof of principle of targeted delivery of EPA-approved Pantoea agglomerans E325 in a paratransgenic system to
control spread of Pierce’s Disease by glassy-winged sharpshooters, (Homalodisca vitripennis) under simulated field
conditions. Engineered microcapsules may address regulatory concerns regarding containment of recombinant
bacteria and environmental spread of foreign genetic material and may represent an important step in translating
paratransgenic science beyond the lab and into the field.
Conclusions: We present, for the first time, a microencapsulation strategy to deliver recombinant bacteria to an
insect and demonstrate targeted release of bacteria into the physiologically relevant region of the insect gut. This is
a first step toward addressing concerns related to field application of recombinant bacteria. Engineered
microparticles may decrease environmental contamination, horizontal gene transfer and competition with native
species by acting as a barrier between recombinant bacteria and the environment.
Keywords: Paratransgenesis, Microencapsulation, Pierce’s Disease, Xylella fastidiosa, Homalodisca vitripennis, Pantoea
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Arthropod-borne diseases remain a major threat to global
health and exact a huge toll on agriculture and food secur-
ity. These diseases are largely controlled through use of in-
secticides that reduce insect populations. Environmental
applications of these chemicals may be associated with
toxic residues and emergence of target insect resistance.
Alternatives to insecticide-based control include paratrans-
genic manipulation of insects with genetically engineered
bacteria that deliver transmission-blocking molecules to
disrupt pathogens within the arthropod vector [1–7].
Though several paratransgenic insect systems are under* Correspondence: tuanravi@gmail.com
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ized, largely due to lack of delivery methods that target
transformed bacteria to the arthropod while minimizing
collateral spread of foreign DNA. The United States Envir-
onmental Protection Agency (EPA) has issued guidelines
for introduction of genetically engineered (GE) species that
state that GE organisms must: (a) Be contained to specific
environments of introduction, (b) Not out-compete native
species for resources, (c) Minimize foreign gene contamin-
ation (horizontal gene transfer) into native gene pools [8].
Here we report a novel strategy for delivery of genetically-
engineered bacteria in a paratransgenic system that targets
the glassy-winged sharpshooter (Homalodisca vitripennis),
a pest of grapes and citrus that spreads the pathogen,
Xylella fastidiosa [9–12]. Using simple and inexpensive
materials for bioencapsulation [13–16] of the engineered
symbiotic bacterium, Pantoea agglomerans, we demonstrateicle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
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trolled conditions with an alginate hydrogel that is tuned
to release its bacterial payload during xylem flow into the
foregut of the insect. By deploying a microencapsulation
system that permits gated delivery of the bacterial payload
to the arthropod, while greatly minimizing release in the
environment, we believe that robust field-applicable tech-
nologies for paratransgenic control of arthropod-borne
diseases will be possible.
Results
A paratransgenic model for the glassy-winged
sharpshooter (GWSS)
Pierce’s Disease (PD) of grapevines, caused by the bacter-
ium Xylella fastidiosa, is a devastating disease of grapes that
threatens grape production worth $3.2 billion and wine
production worth $18.5 billion in California [17, 18]. Para-
transgenic sharpshooters can be an answer to the threat
posed by PD. Early attempts to establish paratransgenic
sharpshooters were focused on the GWSS symbiont Alcali-
genes xylosoxidans denitrificans [10]. However, concerns
that this bacterium may be a nosocomial human pathogen
led us to a grape endophyte bacterium, Pantoea agglomer-
ans E325, currently approved by EPA for control of fire
blight in apples and pears [19]. We hypothesized that the
sharpshooter can acquire P. agglomerans in the same way
as it acquires X. fastidiosa. To test this we genetically engi-
neered this bacterium to express enhanced green fluores-
cent protein (EGFP) and ampicillin resistance and used an
artificial feeding system (AFS) to deliver recombinant bac-
teria to GWSS [20]. The GWSS was able to acquire the
engineered P. agglomerans from the artificial feeding system
and EGFP-expressing P. agglomerans was found binding to
the pre-cibarial and cibarial regions of the insect foregut
(Fig. 1b). We further demonstrated that over a 15-day
period, which is one third of the insect’s lifespan, EGFP-
expressing P. agglomerans persisted in the insect foregut
primarily colonizing the pre-cibarial and cibarial regions
(Fig. 2b). We tested 522 sharpshooters over two seasons to
study P. agglomerans persistence inside the GWSS foregut
and observed 42.2 % foregut colonization with EGFP-
expressing P. agglomerans over a period of 15 days. Car-
riage of P. agglomerans in the foregut of sharpshooters was
not affected by time (p = 0.1979; chi-squared test). This
confirmed that, once acquired by the insect, P. agglomerans
persisted in the foregut for at least two weeks. Colonization
with EGFP-expressing P. agglomerans occurs in the same
spatial niche as the pathogen X. fastidiosa (Fig.1b) [21, 22],
suggesting that P. agglomerans may be used as a delivery
vehicle for paratransgenic control of Pierce’s Disease.
Microencapsulation strategy for paratransgenic control
We developed a biopolymer microencapsulation system
for paratransgenic manipulation of sharpshooters with 4overall goals: (1) encapsulation of transgenic bacteria to
keep them alive, contained and prevent horizontal gene
transfer to environmental bacteria (2) release of bacterial
payload from capsules tuned to specific physiologic condi-
tions within the arthropod to minimize environmental
contamination (3) release of bacteria from the capsules to
colonize the target region of the sharpshooter where path-
ogens reside and (4) use of encapsulation materials that are
inert in the insect without adverse physiological impact.
A suitable polymer
We have developed a calcium-alginate microcapsule for
containment of EGFP-expressing P. agglomerans (Fig. 3).
To ensure that the particles would fit in the proboscis of
the sharpshooter, we used a modified aerosolization-
coascervation process to generate micron-sized particles.
The particle size varied from 6–90 μm, with 57 % of parti-
cles in the range of 22–44 μm (Additional file 1: Figure S3).
By altering the particle composition, we were able to
achieve rapid and sustained release of bacterial payload in
response to sudden hydration. Calcium-alginate based mi-
croparticles (in absence or presence of glycerol) resulted in
sustained release of bacteria over a period of 7 days in re-
sponse to hydration, which was significantly higher than
calcium/barium-alginate microparticles (Additional file 2:
Figure S4, p < 0.0001). Maximum release of P. agglomerans
(CFUs = 1.03X105) was observed from calcium-alginate mi-
croparticles with 10 % glycerol over a period of 7 days,
while minimum (CFUs = 7.33) release was observed from
calcium/barium-alginate microparticles. Based on these re-
sults we decided to engineer calcium-alginate based micro-
particles for acquisition experiments to achieve a quick as
well as sustained release of bacteria inside the insect foregut
after acquisition of microparticles by the sharpshooters dur-
ing xylem feeding.
The encapsulation process protected P. agglomerans from
desiccating conditions, which are expected during periods
of coating on plants prior to ingestion by the sharpshooter
(Fig. 4). Under extreme desiccation 100 % of unencapsu-
lated P. agglomerans died within 7 days; on the other hand
only 2 log decrease in colony forming units (CFUs) was ob-
served when encapsulated P. agglomerans were exposed to
desiccation for the same time period (Fig. 4, p < 0.001). We
further observed that calcium-alginate microparticles were
able to keep P. agglomerans alive for 30 days, though the
number of CFUs in microparticles decreased over time.
This survival of bacteria during desiccation is important, as
similar conditions are expected during summer in grape
growing areas of Southern California.
Addition of 0.5-1.0 % of India ink to the particle confers
high-level UV-resistance, again a desirable quality during
periods of application on plants in the summer time
(Fig. 5). Exposure of both encapsulated and unencapsu-
lated P. agglomerans in the absence of India ink to UVC
Fig. 1 Glassy-winged sharpshooters acquired EGFP-expressing P. agglomerans from an artificial feeding system. (a) Glassy-winged sharpshooters
were allowed to feed on P. agglomerans through artificial feeding system for 48 h. These insect were then kept on naive plants for 24 h to flush
out the unbound bacteria from the foregut before dissection. (b) Image showing EGFP expressing P. agglomerans colonizing the foregut of GWSS.
Inset: A higher magnification of same image showing P. agglomerans colonizing cibarium and precibarium of the GWSS
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cant reduction in CFUs over a period of 60 min when
P. agglomerans mixed with alginate and India ink were
exposed to UVC (Fig. 5, p = 0.051). However, when Ca-
alginate microparticles containing India ink were exposed
to UVC there was one log reduction in P. agglomerans
CFUs in the first 5 min, (Fig. 5) and CFU numbers
remained steady thereafter for next 55 min. We speculate
that bacteria present on the surface of microparticles were
exposed to UVC and were killed in the first 5 min of ex-
posure, but the bacteria embedded in the microparticles
remained protected.We believe that calcium-alginate-10 % glycerol hydrogel
particles with India ink, which protected against dehydra-
tion and UVC, are ideally suited to deliver transgenic
P. agglomerans under field conditions to the glassy-winged
sharpshooter. We hypothesized that these particles will
swell during xylem flow and release the bacterial payload
into the foregut of feeding insects.
A proof-of-concept
Glassy-winged sharpshooters were able to acquire
P. agglomerans from alginate-based microparticles painted
on grape plants. In a control group, GWSS fed on plants
Fig. 2 EGFP-expressing P. agglomerans persisted inside the foregut of the glassy-winged sharpshooter. (a) GWSS were fed EGFP-expressing
P. agglomerans via an artificial feeding system for 48 h. The insects were moved to naive grape plant for 24 h to wash out unattached
bacteria. They were subsequently housed on another naive grape plant for up to 15 days. Insects were collected daily, and processed as
described. Homogenates were plated on LB plates to determine the presence of P. agglomerans. (b) Percent of GWSS carrying EGFP-expressing
P. agglomerans over a period of 15 days. No difference in proportions of GWSS carrying EGFP-expressing P. agglomerans was observed. p = 0.1979 by
chi-squared test for homogeneity
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the insects acquired P. agglomerans, which was signifi-
cantly higher than the number of GWSS that acquired
P. agglomerans from plants painted with encapsulated
P. agglomerans (Fig. 6, p = 0.016). Amongst the groups
of sharpshooters fed on encapsulated P. agglomerans
maximum colonization was observed in insects acquiring
P. agglomerans from 1 % alginate-based microparticles
(51.8 %) followed by 2 % (38.5 %) and 3 % (35.7 %)
alginate-based microparticles. Though an increase in al-
ginate concentration decreased P. agglomerans acquisition
by the GWSS, it was not statistically different between
three tested concentrations of alginate - 1, 2 and 3 %
(Fig. 6, p = 0.476). Unencapsulated treatments resulted in
the maximum CFUs per insect head (mean CFUs = 245.4
± 80.4) and minimum CFUs per head were observed intreatments using 3 % alginate microcapsules (mean CFUs
= 52.1 ± 22.7) (Fig. 7). We did not observe significant dif-
ference between Pantoea CFUs acquired by the insects
from microparticles engineered with 1, 2 or 3 % alginate
(Fig. 7, p = 0.33).
Though the association between alginate concentra-
tion and Pantoea acquisition did not attain statistical sig-
nificance, there was a trend toward decreased Pantoea
levels in GWSS with increasing alginate in microparti-
cles. This suggests that manipulation of polymer com-
position may alter levels of bacterial colonization in the
sharpshooter foregut.
Discussion
Here, we report a new paratransgenic strategy for control
of Xylella transmission by the glassy-winged sharpshooter,
Fig 3 Microparticles containing EGFP-expressing P. agglomerans. (a) Calcium-alginate microparticles containing EGFP-expressing P. agglomerans
(600×). (b) Same field under fluorescence. (600×)
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agent for biocontrol of certain crop diseases, has been
genetically modified using plasmid pT3078, which has the
bla gene as a marker, to express recombinant EGFP in the
foregut of GWSS. We have demonstrated robust EGFP
expression in the insect foregut, in the region that harbors
the plant pathogen, X. fastidiosa. Furthermore, we report
the use of a simple and inexpensive microencapsulation
strategy to contain engineered Pantoea and release the
modified bacteria during conditions of xylem flux into the
anterior mouthparts of the feeding insect. Our results
represent the first iteration of this paratransgenic delivery
system. Refinement of polymer chemistry and capsuleFig. 4 Bacterial survival under extreme dehydration. Encapsulation of P. ag
unencapsulated controls during desiccating conditions. Unencapsulated P.
P. agglomerans survived for a monthapplication may increase the percentage of GWSS that
acquire transgenic Pantoea in future trials. Chemical func-
tionalization of the polymer backbone to enhance bacter-
ial release along with refined methods of increasing
bacterial CFUs per capsule are currently underway.
We propose the use of an EPA approved biocontrol
agent, P. agglomerans E325, as a paratransgenic control
vehicle for PD. P. agglomerans colonized the foregut of
the insect from both an artificial feeding system and
plants painted with unencapsulated and encapsulated
bacteria. P. agglomerans persisted in the insect foregut
over the entire duration of testing, up to15 days. The
15 -day period is significant since it represents close toglomerans significantly increases bacterial viability compared to
agglomerans died in a week after dehydration, while encapsulated
Fig. 5 P. agglomerans survival after exposure to UVC light. Encapsulated and unencapsulated P. agglomerans in the absence of dye were killed
after exposure to UVC within 20 min., while both encapsulated and unencapsulated P. agglomerans in the presence of dye were able to
withstand UVC exposure for 60 min
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applications of this approach could involve bi-weekly
delivery of encapsulated bacteria to grape plants, thus
offering fresh inocula to GWSS on a regular basis.
P. agglomerans can be engineered to produce anti-XylellaFig. 6 Glassy-winged sharpshooters acquired EGFP-expressing P. agglomerans
carrying EGFP-expressing P. agglomerans in their foregut. A higher percent of G
P. agglomerans than from plants painted with encapsulated P. agglomerans.*
test for homogeneitymolecules such as antimicrobial peptides (AMPs) or anti-
Xylella antibodies to block X. fastidiosa. We have used
plasmid pT3078, which has the bla gene as a marker in
addition to an EGFP gene. However, for field application,
Pantoea lines expressing anti-Xylella molecules withoutfrom calcium alginate microparticles. Percent glassy-winged sharpshooters
WSS acquired P. agglomerans from plants painted with unencapsulated
p < 0.05 by chi-squared test for homogeneity.** p > 0.05 by chi-squared
Fig. 7 Bacterial CFUs per insect head. P. agglomerans (EGFP-expressing) colony forming units (log10) per insect head. No difference in P. agglomerans
CFUs acquired by the GWSS from plants painted with unencapsulated or encapsulated P. agglomerans was observed. p > 0.05 by one-way ANOVA with
Tukey Simultaneous Tests for means with unequal variance
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lines with fluorophore genes or REDantibody genes as
markers are under development for field release. These
strategies, coupled with a refined delivery system, will pro-
duce a robust toolset in the battle against GWSS-
mediated PD transmission.
Field use of paratransgenic control for arthropod-borne
diseases remains a future prospect, largely due to concerns
about the fate of engineered bacteria. In the current model,
we believe that environmental risks associated with re-
lease of foreign genes will be reduced. First, plasmid
decay for the recombinant P. agglomerans (Additional
file 3: Figure S2) occurs at the rate of 0.0533 % per bac-
terial generation; thus engineered bacteria are expected
to revert to wild-type forms. Furthermore, engineered
P. agglomerans grows at a rate comparable to wild-type
counterparts (Additional file 4: Figure S1), suggesting
that it cannot out-compete the native organism. Second,
we have encased the recombinant symbiont in an alginate
particle that inhibits release of payload into the environ-
ment. Physical contact between engineered bacteria and
native bacteria of the rhizosphere or phytosphere is
greatly impeded by the presence of capsules. Thus hori-
zontal gene transfer between engineered P. agglomerans
and commonly present bacteria of environmental con-
sortia - a very rare event that occurs in the 10−8 to 10−9
range (data not shown) - should be further diminished.
The overall aim of this strategy is to reduce horizontal
gene transfer to levels that are acceptable to regulatory
agencies, rather than eliminating gene flow. Abolishing
gene flow between environmental bacteria is an unreal-
istic goal. However, by providing a physical barrier viamicroparticles we can minimize exchange between the
large number of freshly released bacteria used in plant
inundation and environmental microbes, with the aim
of reducing unwanted gene flow.
We have contained engineered P. agglomerans using
calcium-alginate microparticles. To deliver the bacteria
to GWSS, we have chosen to paint growing grape
shoots, thus facilitating ingestion of the organisms dur-
ing insect feeding. GWSS and other sharpshooters are
xylem feeders [21]. They initially contact a plant surface
with the tip of their stylet before penetrating into xylem
vessels [22]. We hypothesize that bacteria-laden micropar-
ticles that have been painted on plant shoots will contam-
inate the lumen of the insect’s stylet. During the sucking
of xylem, hydrostatic pressure gradients as high as
0.24 MPa/cm [23], will cause rapid swelling of the alginate
hydrogel and release Pantoea into the cibarial region of
the sharpshooter’s foregut. To optimize release of bacteria
from the microcapsules and enhance colonization of the
insect, hydrogels may be tuned by varying the compos-
ition and concentration of divalent cations (Ca++, Ba++) as
well as alginate (Figs. 6 and 7).
Over 80 % of GWSS that were exposed to unencapsu-
lated (naked) Pantoea during feeding became colonized
with the bacteria, at a mean CFU value of 245.4 ± 80.4.
(Figs. 6 and 7). We tested microparticles containing 1 %,
2 % and 3 % alginate (w/v) in the hydrogel. In all cases,
there was a significant reduction in Pantoea acquisition
when compared to the control group (GWSS exposed to
unencapsulated bacteria) (Fig. 6). When an alginate con-
centration of 1 % (w/v) was used, target GWSS acquired
Pantoea at a rate of 51.8 % with a mean CFU count of
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amongst the tested alginate concentrations and we believe
that 1 % alginate particles merit further attention. Rates of
acquisition of encapsulated Pantoea by target GWSS may
have been lowered for several reasons. First, it is likely that
the experimental insects represented a heterogeneous
population. It is difficult to maintain homogeneous GWSS
population under controlled conditions, thus, we used
field-collected insects that were previously colonized with
environmental bacteria, genetically distinct and of varying
ages through the course of the summer. Second, we used a
very limited time frame for acquisition of bacteria through
feeding by GWSS. It is likely that future field applications
that employ multiple treatments of plants with greatly pro-
tracted contact time between GWSS and particles will
increase colonization rates in the insect. Third, many re-
finements in particle composition are possible. We are
exploring use of particles made of other materials that
would dissolve in the presence of enzymes present in the
insect saliva to better release the bacterial payload. Attrac-
tants and feeding stimulants may be incorporated to en-
hance bacterial delivery. Indeed, future versions of the
microencapsulation-delivery system should result in higher
rates of target insect colonization with engineered Pantoea.
Microencapsulation is a first step toward addressing
concerns associated with paratransgenic manipulation of
arthropods. In this proof of principle, we deployed mi-
crocapsules to deliver a recombinant bacterium to an in-
sect. We designed the alginate particles to swell under
very high hydrostatic pressures encountered during
xylem flux and to decrease contact between engineered
bacteria and the environment during periods of applica-
tion and residence on plants. Microencapsulation will
decrease direct interactions of released bacteria with
other epiphytes when compared to unencapsulated bac-
teria. This should also decrease the interactions of re-
leased bacteria with rhizosphere organisms. We believe
this is a first step toward targeted delivery of recombin-
ant bacteria to arthropod vectors of disease. In ongoing
projects, we are designing more advanced particles that
respond to specific physiological cues within insects,
such as pH and blood products, to establish a platform
for field use of paratransgenics.
Based on this technology, microcapsule-based delivery
of transgenic bacteria to arthropods of clinical signifi-
cance (sand flies, kissing bugs, mosquitoes) for human
vector-borne disease prevention becomes a real and
logical extension, signifying a paradigm shift in para-
transgenic techniques from the lab to field settings. A
microparticle-based recombinant-bacterial release strat-
egy could make paratransgenic control of Chagas disease
and malaria - for which paratrangenic manipulation has
been shown to decrease parasite load inside the vector -
and other vector-borne diseases a reality.Conclusion
This is the first example of the use of microencapsulation
to deliver recombinant bacteria to an insect gut. We have
demonstrated that transgenic symbiotic bacteria can be
delivered to the appropriate physiological niche within a
disease-transmitting arthropod. Furthermore, by acting as
a barrier between transgenic bacteria and the outer envir-
onment these microparticles should reduce competition
between the recombinant bacteria and native species, en-
vironmental contamination and horizontal gene transfer.
This platform may be expanded to deliver recombinant
bacteria to other disease-transmitting arthropod vectors,
thus facilitating field use of paratransgenic control.
Methods
Bacterial culture
P. agglomerans E325 culture was maintained on Luria
Bertani (LB) agar at 30 °C or in LB broth at 30 °C at 180 rpm.
Preparation P. agglomerans E325 competent cells
Bacterial cells were grown in 100 ml of LB medium at
30 °C with shaking at 175–180 rpm. When OD600 was
reached 0.4-0.6 the cells were harvested by centrifuga-
tion at 4000 rpm for 10 min at 4 °C. These cells were re-
suspended in 40 ml of ice cold Inoue solution and
harvested by centrifugation at 4000 rpm for 10 min at
4 °C. Bacterial cells were then resuspended in 10 ml of
Inoue transformation buffer. To this solution 0.7 ml of
DMSO was added and the cells were stored in ice for
10 min. Aliquots of 70 μl were made in microcentrifuge
tubes and immediately snap frozen in liquid nitrogen.
The competent cells were then stored at −80 °C.
Transformation of P. agglomerans E325 with pT3078-5
Competent P. agglomerans cells were removed from −80 °C
freezer, thawed and kept on ice for 10 min. Two μl of
plasmid pT3078-5 was added to the cells. pT3078-5 has
an EGFP gene and bla gene (ampicillin resistant) as
markers. The cells were incubated on ice for 30 min
followed by a heat shock at 42 °C for 90 s. The tubes
were then transferred to ice for 2 min. The cells were
recovered by adding 800 μl LB medium and incubated
at 30 °C with shaking at 180 rpm for 2 h. These cells
were then transferred on to the LB agar supplemented with
carbenicillin (100 mg/liter of media) and incubated over-
night at 30 °C. Next day single colonies were plated on
LB agar with carbenicillin. Transformed P. agglomerans
cells were tested for florescence and confirmed by EGFP
gene PCR.
Growth comparison
Wild-type P. agglomerans and EGFP-expressing P. agglom-
erans were grown overnight in LB and LB + carbenicillin,
respectively, to a stationary phase. They were then diluted
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shaker incubator at 200 rpm. OD600 readings were taken
hourly until cultures reached stationary phase.
Invitro plasmid stability
Transformed P. agglomerans were grown in LB supple-
mented with carbenicillin for 10 h at 28 °C with shaking
at 175–180 rpm. These cells were diluted to ~1000 cells/
ml and were grown for 10 h (approx. 15 generation) in
25 ml LB broth without antibiotic selection. After 10 h
of growth log phase cells were added to 25 ml fresh LB
broth to a final concentration of ~1000 cells/ml and
were grown again. This procedure was repeated 5 times
(total of 75 generation). Every 10 h, while transferring
the cells to fresh medium, a fraction of cells was ali-
quoted and grown overnight on LB agar without any
selection. The next day 100 random colonies were
selected and streaked on LB agar supplemented
with carbenicillin.
Acquisition of P. agglomerans to the GWSS using artificial
feeding system
The EGFP plasmid containing P. agglomerans was grown
overnight in LB broth supplemented with carbenicillin.
The next morning bacteria were centrifuged at 4000 rpm
for 10 min followed by washing twice with the PBS. The
bacterial cells were then resuspended in a solution of PBS
(0.2×) and sugar (0.2 %). This solution was filled into plas-
tic tubes with inner and outer diameter 1/8″ and 3/16″ ,
respectively. These tubes were placed in 2.5″diameter
vials individually. The vials containing the tubes were
called the artificial feeding system (AFS). The control AFS
tubes were filled with the PBS-sugar solution without bac-
teria. GWSS, collected from the citrus orchard of Agricul-
ture Operations, UC, Riverside, were put into the control
AFS and the bacteria containing AFSs. These insects were
given an acquisition access for 48 h.
Maintenance of sharpshooters
After an acquisition access of 48 h the insects were
transferred to an insect cage containing grape plants for
24 h to flush out the unattached bacteria. After 24 h of
flushing, the insects were shifted to a new insect cage
with clean grape plants. The control (naïve) insects from
the acquisition experiment were also transferred to the
clean plants. Everyday 5–15 insects were taken out from
the cage for the bacterial isolation.
Isolation of P. agglomerans from insect heads
Everyday 5–15 sharpshooters were taken out from bac-
teria and control groups and surface sterilized in 70 %
ethanol and 10 % bleach followed by washing twice with
autoclaved sterilized water. The heads of surface steril-
ized insects were cut with a sterile surgical blade andwere homogenized in 100 μl PBS using a homogenizer.
This solution was plated on carbenicillin supplemented
LB agar plates.
General materials and method for alginate experiments
Protonal LF10-60 alginate (FMC Biopolymer, Sweden)
was prepared at 1-3 % (w/v) concentration in de-ionized
water and autoclaved prior to use. Bacterial cultures
were grown in LB broth overnight at 30 °C to plateau
phase in 15 ml culture tubes, pelleted at 4000 RPM at
4 °C for 15 min, washed twice with sterile 1× PBS, re-
pelleted at 4000 RPM and supernatant decanted and re-
suspended in 3 ml sterile 1× PBS before incorporating
into the alginate. Bacterial-alginate suspensions were uti-
lized immediately after mixing. All experiments were
performed in triplicate. Viable colony forming units (CFUs)
were evaluated using the pour plate method on selection
agar. Particle sizing was accomplished on a Microtrac
s3500 laser diffraction analyzer (Microtrac Systems).
Synthesis of calcium-alginate (Ca-ALG) or calcium/
barium-alginate (CB-ALG) microparticle
Alginate-bacterial suspension was produced as men-
tioned above. The resulting mixture was atomized from
an alcohol-sterilized airbrush into a vat containing sterile
0.05 M CaCl2 with constant agitation from a distance of
20 cm. The resulting microparticles were allowed to
harden for 45 min and then harvested via vacuum filtra-
tion through a sterile Nalgene filter-funnel with two
pieces of sterile Nylon mesh (pore sizes of 50 μm and
35 μm respectively) acting as filters. The microparticles
were harvested from the mesh and stored for future use.
In the case of CB-ALG microparticles, an equal vol-
ume of BaCl2 was added to the CaCl2 solution after the
45 min gel time and the microparticles were allowed to
further gel for an additional 20 min. Microparticles were
then collected as described.
Synthesis of carbon-calcium-alginate (CC-ALG)
microparticles
For all experiments relating to carbon-calcium alginate
particles, the alginate-bacterial suspension was mixed
with 1 % vol/vol of sterile India Ink prior to particle gel-
lation. The rest of the protocol was left unaltered.
Dehydration of Ca-ALG microparticles
Bacteria-containing Ca-ALG were produced as previously
described. Ten gram P. agglomerans Ca-ALG microparti-
cles (1X107 CFUs/g) or 10 gm P. agglomerans in 5 %
glycerol (v/v) slurry (1X107 CFUs/g) were then under ster-
ile conditions transferred into sterile 10 cm petri dishes
and allowed to dry to constant weight under ambient con-
ditions and atmosphere (27 °C, 5-7 % RH) overnight. Over
the course of several weeks at various time points 1 gm of
Arora et al. BMC Biotechnology  (2015) 15:59 Page 10 of 11dry slurry or dehydrated microparticles was transferred
into fresh sterile 0.15 M sodium citrate and allowed to re-
hydrate/dissolve for 1 h and then serially diluted and
plated on selection agar and incubated overnight. Viable
CFUs were assessed based on colony count.
Survival of encapsulated P. agglomerans E325 under
highly sterilizing UVC conditions
Bacteria-containing Ca-alginate microparticles both with
and without India Ink dye were produced as previously
described. Ten grams of encapsulated P. agglomerans
E325 containing 2.0 % (v/v) India Ink were placed in
sterile open petri dishes 30 cm directly under a colum-
nated UVC germicidal lamp. Samples were exposed to
sterilizing radiation for 0–60 min, during which samples
were chosen at random at various time intervals and
placed in fresh sterile microcentrifuge tubes containing
1 ml sterile 0.15 M sodium citrate solution and left to
dissolve over 1 h. The liberated microbes were serially
diluted and plated on LB agar and left to incubate at
30 °C overnight. CFUs were counted the following day.
Diffusion from CA-ALG and CB-ALG microparticles
Bacteria-laden microparticles were produced as previ-
ously described. 1 g of microparticle slurry was mixed
with 1 ml of sterile water in a 1.5 ml microcentrifuge
tube and allowed to stand at 4 °C for the prescribed
time. At various time intervals throughout the experi-
ment, the tubes were vortexed vigorously for 10-15 s to
re-suspend any diffused bacteria. The microparticles
were allowed to settle for 5 min and then 50 μl aliquots
were removed and serially diluted. 50 μl aliquots of each
dilution were then plated on selection agar and the
plates were incubated overnight at 30 °C to determine
viable CFUs that had diffused from the microparticles.
P. agglomerans acquisition through microparticles
EGFP-expressing P. agglomerans containing microparti-
cles were engineered using a 1, 2 or 3 % alginate as de-
scribed above. Encapsulated bacteria were irradiated
three times with UVC for 90 secs to kill any unencapsu-
lated bacteria during the production process. These mi-
croparticles were then mixed with 10 % glycerol and 3 %
guar gum and were applied to the grape plants. Field
collected sharpshooters were allowed to feed on these
plants for 24 h. As a control unencapsulated bacteria
mixed with 10 % glycerol and 3 % guar gum were ap-
plied to the grape plants. After 24 h the sharpshooters
were removed from the plants and surface sterilized.
The foregut and midgut contents were homogenized as
described above using a homogenizer. The foregut and
midgut contents were plated on LB + carbenicillin agar
plates and were incubated at 30 °C. The CFUs were
counted after 24 h.Statistical analysis
Number of GWSS carrying P. agglomerans were
compared using Chi-squared test for homogeneity. P.
agglomerans CFUs in various experiments with different
treatments were analyzed by Tukey’s test for multiple
comparison after taking log values of CFUs. All the
values are shown as mean ± S.E. Statistical analysis were
performed using Minitab version 17 for windows 7.
p values < 0.05 were considered significant.Additional files
Additional file 1: Figure S3. Size distribution of P. agglomerans
containing microparticles.
Additional file 2: Figure S4. Diffusion of microencapsulated
P. agglomerans from Ca2+ and Ca2+/Ba2+ cross-linked microparticles. Use
of barium as a cross-linker greatly reduced the diffusion of bacteria from
the microparticles.*, **, *** and **** p < 0.001 by one-way ANOVA with
Tukey Simultaneous Tests for means with unequal variance compared to
Ca-Alg and Ca-Alg + 10 % Glycerol microparticles on days 1, 3, 5 and 7,
respectively.
Additional file 3: Figure S2. Loss of plasmid pT3078-5 by
P. agglomerans over time.
Additional file 4: Figure S1. Comparison of growth of wild
type P. agglomerans and EGFP-expressing P. agglomerans.Abbreviations
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